Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05733325 · ClinicalTrials.gov registry record
Diet-induced Elevations in LDL-C and Progression of Atherosclerosis
A clinical trial, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT05733325 is a clinical trial that has completed, run by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT05733325 has completed, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This is an observational study examining the progression of subclinical coronary atherosclerosis in healthy participants who have an elevated LDL-C (above 190mg/dl) secondary to diet not associated with genetic familial hypercholesterolemia (FH). This study participants are classified to be Lean-Mass-Hyper-Responder (LMHR).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-10-18 |
| Est. Completion | 2024-02-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05733325
The ClinicalTrials.gov registry entry for NCT05733325 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05733325 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05733325 about?
NCT05733325 is a clinical study titled "Diet-induced Elevations in LDL-C and Progression of Atherosclerosis". This is an observational study examining the progression of subclinical coronary atherosclerosis in healthy participants who have an elevated LDL-C (above 190mg/dl) secondary to diet not associated with genetic familial hypercholesterolemia (FH). This study participants are classified to be Lean-Mas...
What is the current status of trial NCT05733325?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2021-10-18. Estimated completion is 2024-02-12.
Who is sponsoring clinical trial NCT05733325?
This trial is sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.